Axys: Selective disacquisition

Axys Pharmaceuticals Inc. - then Arris Pharmaceutical Corp. - acquired toolkit company Sequana Therapeutics Inc. in 1997 for $166 million in stock, a price many investors at the time fretted was too high (see BioCentury Extra, Nov. 4, 1997).

Last week AXPH announced that it

Read the full 458 word article

How to gain access

Continue reading with a
two-week free trial.